Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer.
about
When Prostate Cancer Circulates in the BloodstreamEmerging roles of extracellular vesicles in the nervous systemNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer.Glioblastoma extracellular vesicles: reservoirs of potential biomarkers.Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.No more monkeying around: primate malaria model systems are key to understanding Plasmodium vivax liver-stage biology, hypnozoites, and relapses.Molecular screening of cancer-derived exosomes by surface plasmon resonance spectroscopy.Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol.Interactions of tumour-derived micro(nano)vesicles with human gastric cancer cells.Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.Extracellular vesicle isolation and characterization: toward clinical applicationMelanoma Affects the Composition of Blood Cell-Derived Extracellular Vesicles.Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer.Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease.Extracellular vesicles: emerging targets for cancer therapy.Toward routine detection of extracellular vesicles in clinical samples.Extracellular RNA mediates and marks cancer progression.Extracellular Vesicles - Powerful Markers of Cancer EVolution.Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational DayInhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA contentExosomes in Cancer DiagnosticsThe role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.Exosome: emerging biomarker in breast cancer.Platelets, circulating tumor cells, and the circulome.Role of exosomal proteins in cancer diagnosisBarriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras.The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis.Cytotoxic stress induces transfer of mitochondria-associated human endogenous retroviral RNA and proteins between cancer cells.Identification of circulating miRNA involved in meat yield of Korean cattle.In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes.Biodistribution, Uptake and Effects Caused by Cancer-Derived Extracellular Vesicles.Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer TherapiesThe implications of signaling lipids in cancer metastasisExtracellular Vesicles, Ageing, and Therapeutic Interventions
P2860
Q26768470-953C3B58-D5D3-46E4-812A-6DE1BC74C5EDQ27025173-8C5BEF76-6FCB-4022-9354-6648D76F94D6Q28078448-7FCBA6A8-322A-404C-8551-5C5D2FE2D7E7Q33755190-0A8AF08A-F21B-4889-A356-9A42A360B5CAQ33917559-2EEF40B2-D80A-4BFA-9C6D-6B4092F1ACCCQ33968783-2D6C1740-E977-4BC0-B70F-DEC907D65B2CQ35122209-403534E0-04C5-40C3-9DF3-499E63257044Q35168191-AD7D9755-5773-4C3B-956F-82121CF66EBBQ35218865-C1C40A45-4C39-4E1C-B36E-9A10F0A1AB2AQ35771700-E8AEC671-B5C4-4AEF-9228-FFF754D55710Q36329476-4046BF32-5A9B-4C14-9FD0-FF93FE6CF49EQ36337082-7EE294DE-4D77-4D98-8680-D8E0E0880F5BQ36511698-2D635241-F508-4339-B824-F531807C81F5Q36737951-66C75309-CB5D-4A6F-BAAF-E88595D4CAEAQ37124913-CE14BD2D-1471-4E15-93CF-AA3898ED4A6CQ37240065-40EBD457-A056-489B-AF4A-10BDECF5E70BQ37592190-CF388C39-6A28-4D65-B078-6D9A539C389EQ37673863-0E07C623-21A1-4639-9794-A6302F7943C8Q37724539-AD629E76-C4A5-4A72-9F9D-66804FA8A163Q38115105-FD06A52A-2992-46F2-9EFA-700383E2A982Q38202336-8D30A5CA-728D-476D-B765-1E3DDB3FA2EFQ38205945-A335B4BF-E283-4E33-B777-8A581AF966B2Q38208372-8C718390-AEAB-4C1F-9EEA-CEC0531FAA0FQ38335195-530BE0E9-1A52-4053-BB7D-9DDCFD184558Q38379177-E7F27A96-595A-4FE5-A35A-4C51F23EC19CQ38843843-EB7B91BF-A194-4299-B519-ED202F33DDF0Q39085664-325F80F9-3EA7-49D3-BB10-59C1031CADAEQ39123707-303F86FB-2C94-4BF8-92B6-2C75A6087B4FQ39237769-FDE4872E-3A8E-4AE8-8F65-2A578E1C6135Q39408199-4986A4A3-0C9F-45CB-9E1E-9BD73B635DF4Q41556414-507E5CFB-BFFC-4256-BF9F-A3EABCD26317Q42330185-2A4549F0-6959-49F5-8C6C-3E9302BFBF40Q47132833-034A77C3-C1A3-4245-B0BD-5D7D21ECF4AAQ47140969-295069A0-3124-4CF4-8EE7-4D15DCC4B6BBQ50203587-E010FF9B-861A-418E-B04A-C223D6183FE3Q51013152-6F800BA8-1621-4A23-B502-79F05AB3720CQ55431439-AC73E7A8-2040-45F5-A4E3-5E7C71B9D31EQ57469731-234AF653-E9BF-44CB-B226-05F4AE8CD5E7Q58705856-21F8FBC6-E26F-4126-8BE5-9DE5DDD932C4Q58766798-D7AC114C-58DF-40BB-A6D3-F86B48053F90
P2860
Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer.
@en
type
label
Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer.
@en
prefLabel
Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer.
@en
P2860
P356
P1476
Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer.
@en
P2093
Janusz Rak
P2860
P356
10.3389/FPHAR.2013.00021
P577
2013-03-06T00:00:00Z